Cargando…

Histamine: a potential cytoprotective agent to improve cancer therapy?

Detalles Bibliográficos
Autores principales:	Martinel Lamas, D J, Nicoud, M B, Sterle, H A, Cremaschi, G A, Medina, V A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	News and Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720909/ https://www.ncbi.nlm.nih.gov/pubmed/26720338 http://dx.doi.org/10.1038/cddis.2015.378

Ejemplares similares

Selective cytoprotective effect of histamine on doxorubicin-induced hepatic and cardiac toxicity in animal models
por: Lamas, DJMartinel, et al.
Publicado: (2015)

Study of the antitumour effects and the modulation of immune response by histamine in breast cancer
por: Nicoud, Melisa B., et al.
Publicado: (2019)

Immunomodulatory role of histamine H4 receptor in breast cancer
por: Sterle, Helena A., et al.
Publicado: (2018)

Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H(4) receptor agonists and opportunity for combination with radiation
por: Massari, Noelia A., et al.
Publicado: (2017)

Radioprotective potential of histamine on rat small intestine and uterus
por: Carabajal, E., et al.
Publicado: (2012)

Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications
por: Nicoud, Melisa B., et al.
Publicado: (2019)

Histamine in cancer immunology and immunotherapy. Current status and new perspectives
por: Sarasola, María de la Paz, et al.
Publicado: (2021)

Protection of Radiation-Induced Damage to the Hematopoietic System, Small Intestine and Salivary Glands in Rats by JNJ7777120 Compound, a Histamine H(4) Ligand
por: Martinel Lamas, Diego J., et al.
Publicado: (2013)

Histamine antagonists promote cancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2023)

Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
por: Xia, Hongping, et al.
Publicado: (2017)

Common Bacterium Induces Histamine Production in Neutrophils
por: Potera, Carol
Publicado: (2012)

Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer
por: Nicoud, Melisa B., et al.
Publicado: (2023)

A minimal ING1b fragment that improves the efficacy of HDAC-based cancer cell killing
por: Boyko, A, et al.
Publicado: (2015)

αTAT1: a potential therapeutic target in cancer?
por: Chien, J-Y, et al.
Publicado: (2016)

Mouse models and anti-HER2 therapies
por: Hanker, Ariella B., et al.
Publicado: (2013)

Neuroprotective and neurorestorative potential of xenon
por: Lavaur, J, et al.
Publicado: (2016)

European physicians don’t like cytoprotective agents?
por: Kawai, Takashi, et al.
Publicado: (2011)

The potential of erythrocytes as cellular aging models
por: Kaestner, Lars, et al.
Publicado: (2017)

First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
por: Besbes, S, et al.
Publicado: (2015)

Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery
por: Brunstein, F, et al.
Publicado: (2006)

Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
por: Pérez-Lloret, Santiago, et al.
Publicado: (2021)

Considering autophagy, β-Catenin and E-Cadherin as innovative therapy aspects in AML
por: Kühn, K, et al.
Publicado: (2015)

Bringing back the help: autologous bone marrow infusion restores CD4(+) T cells in AIDS patients with chronic liver disease
por: Rabson, A B
Publicado: (2013)

Stressing out the Hippo/YAP signaling pathway: toward a new role in Schwann cells
por: Melfi, S, et al.
Publicado: (2015)

P2X(7) receptor activity regulation: the role of CD44 proteoglycan GAG chains
por: Moura, G E D D, et al.
Publicado: (2015)

CRISPR: a new method for genetic engineering – A prokaryotic immune component may potentially open a new era of gene silencing
por: Amelio, I, et al.
Publicado: (2015)

Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Histamine: an undercover agent in multiple rare diseases?
por: Pino-Ángeles, Almudena, et al.
Publicado: (2012)

Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
por: Herranz, Carmen, et al.
Publicado: (2021)

Natural Cryoprotective and Cytoprotective Agents in Cryopreservation: A Focus on Melatonin
por: Marcantonini, Giada, et al.
Publicado: (2022)

AMPK, a key regulator of metabolic/energy homeostasis and mitochondrial biogenesis in cancer cells
por: Chaube, B, et al.
Publicado: (2016)

Antioxidant and Cytoprotective Properties of Cyanobacteria: Potential for Biotechnological Applications
por: Guerreiro, Adriana, et al.
Publicado: (2020)

Melanoma: A model for testing new agents in combination therapies
por: Ascierto, Paolo A, et al.
Publicado: (2010)

Non-canonical autophagy LAPs lupus
por: Simon, A K, et al.
Publicado: (2016)

The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

Bcl-2 together with PI3K p110α regulates cell morphology and cell migration
por: Wan, G, et al.
Publicado: (2015)

Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines
por: Mahbub, A A, et al.
Publicado: (2015)

Muscle Lim Protein (MLP)/CSRP3 at the crossroad between mechanotransduction and autophagy
por: Rashid, M M, et al.
Publicado: (2015)

The APRIL paradox in normal versus malignant B cell biology
por: van Attekum, M H A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0tnvuo3dqmpg4d1v37punv9632